FDA Makes Official MethylGene’s Partial Clinical Hold On ‘0103 Trials
With partner Celgene, the firm had already suspended enrollment in Phase I and Phase II trials due to cases of pericarditis.
With partner Celgene, the firm had already suspended enrollment in Phase I and Phase II trials due to cases of pericarditis.